Table 3

Patients with a PGA changea of 'good', 'excellent' or 'cleared', according to first treatment (assigned at baseline) and last treatment (the treatment that was being received at Week 12)*.

Methotrexate

Cyclosporin

Corticosteroids

Combinedb

Retinoids

All patients


First treatment (n (%))

9/20 (45.0)

7/10 (70.0)

2/8 (25.0)

0/2 (0.0)

0/1 (0.0)

18/41 (43.9)

Last treatment (n (%))

9/18 (50.0)

9/12 (75.0)

4/8 (50.0)

1/2 (50.0)

0/1 (0.0)

23/41 (56.1)


* At the investigators' discretion, six patients were switched between treatments during the study.

aChange from baseline.

bCombined systemic corticosteroids plus methotrexate.

PGA, physician's global assessment.

Papp et al. BMC Dermatology 2006 6:9   doi:10.1186/1471-5945-6-9

Open Data